Geneva Health Forum Archive

Browse and download abstracts, posters, documents and videos from past editions of the GHF

GHF2014 – PS35 – Social Media and Global Health: The “How to” and “What for”

Social Media and Global Health: The "How to" and "What for"
Dr. Greg Martin
Editor-in-Chief, Journal of Globalization and Health, Ireland
Mr. Sebastian Majewski
Senior Communications Officer, Gates Foundation, United States
This session will comprise two presentations followed by questions and discussion about the use of social media in the global health space. Dr Greg Martin (Globalization and Health) will give a brief overview of lessons learned through his experience in using social media to create virtual “communities” across borders. This will be followed by a presentation by Sebastian Majewski (Gates Foundation) in which he will talk about exciting work that is being done using social media monitoring to tackle some of the more urgent public health and development problems globally.

photo greg martinDr. Greg Martin

Dr. Greg Martin is a South African doctor with a masters in public health and an MBA degree. Dr Martin’s involvement in global health has spanned a wide rang of subject matter including maternal and child health, cancer prevention, access to medicine and the treatment and care of people living with HIV, amongst others. He recently stepped down from the role of Director of Elimination of Mother to Child Transmission at the Clinton Health Access Initiative in order to move to Ireland where he recently got married. He is currently with Editor-in-Chief of the journal Globalization and Health and runs a Global Health YouTube channel as well as working as a clinician in a local hospital in Dublin.

Sebastian_Majewski_20131209_0020Mr. Sebastian Majewski

Sebastian Majewski (@sebmaje) is Senior Communications Officer at the Gates Foundation. Guided by social media monitoring and data analysis, Majewski’s evidence-based marketing approach focuses on social media’s potential to influence, inform, and legitimize agenda-setting in the international community. With more than six years’ experience in digital communications for UNICEF, UNDP and UNDESA, Majewski has been at the core of shaping global advocacy strategies for the largest humanitarian organizations.

Sebastian lectures master students of France Business School on social media monitoring, and is a regular speaker at social media conferences such as Social Media Week, Benchmark, and Dreamforce.

GHF2014 – PS33 – Global Health Education: What are the Priorities for the Global Health Curriculum?

PS33 THURSDAY, 17 APRIL 2014 ROOM: 13 ICON_Fishbowl
Global Health Education:
What are the Priorities for the Global Health Curriculum?

Prof. André-Jacques Neusy
Chief executive officer, Training for Health Equity Network , Belgium
Ms. Kristina Graff
Director of Global Health Programs, Woodrow Wilson School of Public and International Affairs, Princeton University, United States
Abstract: Princeton’s University Global Health Program: Research and Teaching at the Nexus of Science, Policy and Social Science
Dr. David Beran
Researcher and Lecturer, Division of Tropical and Humanitarian Medicine, University of Geneva, Switzerland
Mr. Clément Graindorges
Medical Student, Faculty of Medicine, University of Geneva, Switzerland
Ms. Carol Savatier
Medical Student, Faculty of Medicine, University of Geneva, Switzerland
Ms. Eloïse Magnenat
Medical Student, Faculty of Medicine, University of Geneva, Switzerland

AJ Neusy_squareProf. André-Jacques Neusy

André-Jacques Neusy, MD, DTM&H, is Chief Executive Officer and co-founder of Training for Health Equity Network (THEnet). THEnet is a global network of socially accountable schools of health sciences and medicine that aims to produce health equity through optimizing the health workforce, contributing to quality health systems and influencing the determinants of health, particularly in disadvantaged communities.

Dr. Neusy is a retired Professor of Medicine at New York University School of Medicine where he founded and directed the Center for Global Health until 2007. He is a visiting professor in several universities around the world.

Dr. Neusy earned his medical degree at the Free Univ. of Brussels and a Doctorate in Tropical Medicine and Hygiene at the Institute of Tropical Medicine of Antwerp-Belgium. He completed his postdoctoral medical training at New York University Medical Center, joined its faculty in 1974 and became the director of the nephrology section at NYU-Bellevue Hospital Center in 1984.

Dr. Neusy frequently consults on health workforce development for academic institutions, governments and international organizations. He was a past president of the Global Health Education Consortium (GHEC), a consortium of more than 80 North American Universities that have global health programs. Dr. Neusy is an ambassador of US-based Freedom from Hunger. He serves on scientific and health committees of various organizations including the International Society for Urban Health, the American Near East Refugee Association, Capacity-Plus, and the Global Forum on Health Professional Education for the 21st Century at the Institute of Medicine, National Academies of Sciences.

Graff PhotoMs. Kristina Graff

Kristina Graff is Director of Global Health Programs at Princeton University’s Woodrow Wilson School of Public and International Affairs, responsible for overseeing and expanding a broad array of domestic and international research and teaching initiatives. She previously served as the Director of Special Initiatives at the New York City Department of Health’s Bureau of Maternal, Infant and Reproductive Health, where she advanced new programs in teen pregnancy prevention, breastfeeding promotion, sex education and support for high-risk mothers and their infants. On the international front she worked on policy, advocacy and service delivery programs to improve women’s health in developing countries through positions at Women’s Dignity Project and EngenderHealth, and through consultancies with the United Nations Population Fund, Family Care International, and Population Action International. Kristina received her Master in Public Affairs from Princeton University’s Woodrow Wilson School, and she completed her bachelor’s degree at Duke University.

Beran190Dr. David Beran

David Beran is a Researcher and Lecturer at the University of Geneva within the Division of International and Humanitarian Medicine at the Faculty of Medicine.

David is a Swiss national who grew up in Geneva. He holds a BSc in Management with an Emphasis in Marketing. Following his first degree, he worked for a leading Swiss Biotech Company in both Health Policy and Government Relations and Public Relations. He then obtained his MSc in Public Health at the London School of Hygiene and Tropical Medicine. For his Masters’ dissertation, David worked at the WHO looking at ways of preventing Type 2 diabetes in children. David has recently completed his PhD looking at the needs of people with Type 1 diabetes in 13 countries at University College London (UCL).

Before joining the University of Geneva, David was the Project Coordinator of the International Insulin Foundation (IIF) since its establishment in November 2002 until September 2011. As of September 2011 David became Advisor to the Board of Trustees. In parallel to his role at the IIF, David was also based at the Centre for International Health and Development, Institute of Child Health, UCL, where he was a Senior Research Fellow, with both teaching and research responsibilities in the areas of health management, access to medicines, diabetes, chronic diseases and health systems in developing countries.

Dr. Anne Golaz

Golaz-AnneDr. Anne Golaz

Lecturer and Researcher at CERAH, Switzerland

She obtained her Medical Doctor degree and Doctorate in Medicine at the University of Geneva, and a MPH at the University of Washington. She’s Board Certified in Public Health and General Preventive Medicine. She has over 20 years of field experience in humanitarian work and graduate and post-graduate education in public health. She’s worked as a medical epidemiologist for the US Centers for Disease Control and Prevention; as a senior advisor for UNICEF Regional Office for South Asia in Kathmandu and Geneva Office, and for WHO HQ and Regional Offices in Cairo and New Dehli.

Role at the CERAH:

  • Member of the Scientific Committees of the CAS Health in Humanitarian Emergencies and CAS Disaster Management
  • Coordinator CAS Health in Humanitarian Emergencies
  • Coordinator of the Research Methodology course (MAS-DAS)
  • Co-leader of the course Health Interventions in Humanitarian Crises (MAS-DAS week)
  • Co-leader TS Advocacy for Humanitarian Projects in Health

Fields of interest:

  • Public health and epidemiology
  • Reproductive health in humanitarian emergencies
  • Mental health in humanitarian emergencies
  • Genocide prevention
  • Community capacity building
  • Research and evidence generation in humanitarian contexts

GHF2014 – PS14 – Integrating Sexual and Reproductive Health Care in Humanitarian Interventions

PS14 TUESDAY, 15 APRIL 2014 ROOM: 18 ICON_Fishbowl
Integrating Sexual and Reproductive Health Care in Humanitarian Interventions
Dr. Doris Schopper
Professor at the medical faculty of the University of Geneva and director of CERAH, Switzerland
Dr. Anne Golaz
Lecturer and researcher at CERAH, Switzerland
Ms. Wilma Doedens
Technical Adviser on Reproductive Health in Emergencies, Humanitarian Response, UNFPA, Switzerland
Dr. Lisa Thomas
Medical Officer, Department of Reproductive Health and Research, World Health Organization, Switzerland
Ms. Nelly Staderini
Référente médicale- Santé de la reproduction, Reproductive Health Advisor, MSF, Switzerland
Problems related to sexual and reproductive health are the leading cause of death and ill health for women of childbearing age globally. In crises, this vulnerability increases, while access to services decreases. The urgent need for life-saving sexual and reproductive health services has often been neglected and not prioritized in humanitarian responses.  Speakers from UN agencies and INGOs will give a brief overview of some of their sexual and reproductive health programmes, discuss recent achievements, challenges in integrating sexual and reproductive healthcare in humanitarian interventions and ways to advocate for better access to these services during crises.

SCHOPPER-DorisDr. Doris Schopper
Professor at the medical faculty of the University of Geneva and director of CERAH, Switzerland

She obtained a medical degree at the University of Geneva (1978), trained as a specialist in Internal Medicine (1986) and completed a Doctor in Public Health at the Harvard School of Public Health (1992).

Between 1982 and 1990 Doris Schopper spent several years with Médecins Sans Frontières (MSF) in the field. She was president of the Swiss branch of MSF (1991–1998) and twice president of the MSF International Council during this period. In 2001 Doris Schopper was asked to constitute an Ethics Review Board for MSF International.

Since then she has chaired the Board coordinating the ethical review of MSF research proposals and providing advice on ethical matters to the organisation.

Doris Schopper also worked as health policy adviser in the Global Programme on AIDS at WHO headquarters in Geneva (1992-95).

Further international work includes two years as senior health policy adviser at the Swiss Tropical Institute and developing several policies and strategies for WHO (e.g. guideline for policy makers on national policies for violence and injury prevention; strategy for mother-to-child transmission of HIV in Europe; WHO-wide strategy on child and adolescent health).

Professor Schopper has also been responsible for the development of health policies and strategies at the national and regional level in Switzerland (e.g. Swiss National Cancer Control Programme 2005-2010; framework to prevent obesity at the national level; comprehensive health policy for the canton of Geneva). She is member of the board of Pro Victimis Foundation-Geneva since 2003, and president since 2010.

In November 2012, Doris Schopper was appointed member of the International Committee of the Red Cross (ICRC).


  • Director
  • Member of the Scientific Committees of the CAS
  • Coordinator CAS Health in Humanitarian Emergencies
  • Co-responsible Course Health Interventions in Humanitarian Crises

Fields of Interest:

  • Public health in humanitarian contexts
  • Development and analysis of health policy
  • Research ethics in humanitarian contexts
  • Ethics of humanitarian medical intervention
  • HIV-Aids, Cancer


Golaz-AnneDr. Anne Golaz
Lecturer and researcher at CERAH, Switzerland

She obtained her Medical Doctor degree and Doctorate in Medicine at the University of Geneva, and a MPH at the University of Washington. She’s Board Certified in Public Health and General Preventive Medicine. She has over 20 years of field experience in humanitarian work and  graduate and post-graduate education in public health. She’s worked as a medical epidemiologist for the US Centers for Disease Control and Prevention; as a senior advisor for UNICEF Regional Office for South Asia in Kathmandu and Geneva Office, and for WHO HQ and Regional Offices in Cairo and New Dehli.

Role at the CERAH

  • Member of the Scientific Committees of the CAS Health in Humanitarian Emergencies and CAS Disaster Management
  • Coordinator CAS Health in Humanitarian Emergencies
  • Coordinator of the Research Methodology course (MAS-DAS)
  • Co-leader of the course Health Interventions in Humanitarian Crises (MAS-DAS week)
  • Co-leader TS Advocacy for Humanitarian Projects in Health

Fields of interest

  • Public health and epidemiology
  • Reproductive health in humanitarian emergencies
  • Mental health in humanitarian emergencies
  • Genocide prevention
  • Community capacity building
  • Research and evidence generation in humanitarian contexts


Ms. Wilma Doedens

Wilma Doedens is the Technical Adviser on Reproductive Health in Emergencies of the Humanitarian Response Branch of UNFPA. She has worked with UNFPA since 2002. Prior to this she worked with WHO.

Wilma is a Medical Doctor with a public health and reproductive health background. She has extensive field experience in coordinating and implementing reproductive health services in both humanitarian and development settings, working within national health systems as well as with NGOs such as Medecins Sans Frontieres (MSF), International Rescue Committee (IRC) and the International Federation of the Red Cross (IFRC).

She coordinated the writing and publication of the Inter-Agency Field Manual for Reproductive Health in Humanitarian Settings and the Inter-Agency Standing Committee Gender-Based Violence Guidelines, and she is responsible for ensuring technical review and quality improvement of the Inter-Agency Reproductive Health Kits designed to support the implementation of priority reproductive health interventions in disasters.


Dr. Lisa Thomas

Lisa Thomas, MD is a Medical Officer in the Department of Reproductive Health and Research at the World Health Organization in Geneva, where she serves as the focal point for sexual and reproductive health in humanitarian settings.  She is a U.S. Board Certified Obstetrician Gynecologist with subspecialty training in family planning. Prior to joining WHO, she worked for humanitarian, development and donor agencies in over twenty developing countries including conflict and post-conflict settings. She has covered an expansive breadth of public and private sector projects in maternal and reproductive health policy, program design, training, research and monitoring and evaluation.


Ms. Nelly Staderini

Since more than 3 years, Nelly Staderini is in charge of the  Sexual and Reproductive Health and sexual violence in the medical department of Doctors Without Borders in Geneva. After initial training in midwifery and a Public Health Diploma in France, she practiced  in Parisian hospitals and had various functions in humanitarian missions abroad ( Mali , Cambodia, Pakistan, Afghanistan, Guinea , Chad and Burundi ) for non -governmental organizations. She has worked on maternal health issues in general and sexual violence, prevention and treatment of obstetric fistula and the prevention of mother to child transmission of HIV in particular. She is the author of academic works dealing with training of TBAs in Cambodia and midwives in Chad as well as two books: Sage-femme en Afghanistan (Cheminements Editions , 2003) and l' art revisité des matrones, naissances contemporaines en question ( Faustroll Edition, 2011).

GHF2014 – LS02 – Evidence Informed Decision Making in Achieving UHC: the Role of Macro HTA

Evidence Informed Decision Making in Achieving UHC:
the Role of Macro HTA

Dr. Nick Drager
Honorary Professor, Senior Fellow, Global Health Programme, The Graduate Institute, Geneva
Mr. Adrian Griffin
Vice President, HTA Policy, Johnson & Johnson
Dr. Franz Pichler
Director, Global Public Policy, Eli Lilly and Company
Dr. John-Arne Røttingen
Norwegian Knowledge Centre for the Health Services
Dr. Eva Maria Ruiz de Castilla
Executive Director, Esperantra (NPO, Peru)

As a number of countries aspire to implement universal health coverage frameworks, many are looking at methods to best structure their health system to ensure citizens obtain the health services they need. Given cost constrained environments, many low and middle income countries have increasingly focused efforts on prioritization and determining value for investments in health. As such, a significant focus has turned towards the use of research evidence as a tool to support decision making. However, historically, this type of evidence has rarely been applied to support overall health system decision making. In the context of developed countries, a narrow interpretation has placed a significant emphasis on decisions related to coverage and reimbursement of healthcare technologies, such as medicines and diagnostics. 1 Healthcare technologies are only one of several inputs in the overall health system. The organization and delivery of a health care system is a complex matter, which requires a number of decisions regarding the resources necessary to ensure access to services, the mix of interventions required and the means to achieve optimal results.2 Limiting evidence based decision making to coverage decisions tends to obscure the potential role to apply to the overall health system as a whole, such as interventions that facilitate access, service delivery, and aim to improve quality of care.

Therefore, as countries embark towards universal health coverage, it is important that decisions related to coverage of health products and benefits packages are only one part of the discussion. Many low and middle income countries have extensive inefficiencies in their health systems, including issues related to service delivery, quality of care and treatment standards that transcend the need to focus specifically on coverage of health technologies to determine value for investments in health.

This session will explore the role of evidence informed decision making in achieving universal health coverage, looking specifically at the role of "macro" HTA as it is applied to overall health system efficiency and quality of care. This unique session will provide the audience with a view of different perspectives from various sectors in the healthcare space - patient, industry, academic and payer/NGO. Through live interaction, the audience will be able to participate and provide thought provoking questions/answers amongst the group to explore this innovative topic.


Nick Drager M.D., Ph.D
Honorary Professor, Senior Fellow, Global Health Programme, The Graduate Institute, Geneva

Former Director of the Department of Ethics, Equity, Trade and Human Rights and Senior Adviser in the Strategy Unit, Office of the Director-General at the World Health Organization- now is Honorary Professor, Global Health Policy, London School of Hygiene & Tropical Medicine; Professor of Practice, Public Policy and Global Health Diplomacy, McGill University; Adjunct Professor, Department of Epidemiology and Community Medicine, University of Ottawa; Adjunct Research Professor, Norman Paterson School of International Affairs, Ottawa; and Senior Fellow, Global Health Programme, The Graduate Institute, Geneva.

  • Work focuses on current and emerging issues related to global health, in the areas of global health security/diplomacy/governance, foreign policy and international trade and health including intellectual property and health.
  • Extensive experience working with senior officials in over 100 countries and major multilateral and bilateral development agencies in health policy development, health sector analysis, strategic planning and resource mobilization and allocation decisions and in providing strategic advice on health development negotiations and in conflict resolution.
  • Deep experience in global health diplomacy and high-level negotiations on international health security and development issues.
  • Represented WHO, serves as chair, keynote speaker at major international events and conferences; lectures and teaches at Universities in Europe, North America and Asia.
  • Editor/author of books, papers and editorials in the area of global health; global health diplomacy; trade and health including IP; foreign policy and health. Has an M.D. from McGill University and a Ph.D. in Economics from Hautes Etudes Internationales, (the Graduate Institute) University of Geneva.


AdrianGriffinAdrian Griffin
Vice President, HTA Policy, Johnson & Johnson

Adrian Griffin is Vice President, HTA & Market Access Policy at Johnson & Johnson.  He has been involved in the fields of health economics, outcomes research, and reimbursement policy within the healthcare industry for 16 years, with experience across the pharmaceutical, medical device, and diagnostic sectors.

Mr Griffin graduated in Medicinal Chemistry from University College London, obtained a post-graduate teaching qualification from Oxford University, and spent several years teaching chemistry before joining the UK’s Medical Research Council.  He then received his MSc in Health Economics at City University, London, before joining the healthcare industry.  Mr Griffin has held positions at GlaxoSmithKline, Pharmacia, and most recently Johnson & Johnson, where he has been since 2003.

In addition to undertaking outcomes research from the industry perspective, Mr Griffin has also served as a ‘decision-maker’, on the NICE Technology Appraisal Committee, where he has been a committee member for 10 years.  Mr Griffin is also active in numerous multi-stakeholder forums where key issues of HTA and access policy are debated and shaped, such as the HTAi Policy Forum, and initiatives that have brought regulators and HTA agencies together with companies, thus improving transparency and appreciation of different stakeholder perspectives.

Mr Griffin has contributed to several UK industry-government task-force and working groups, aimed at developing policy and processes to improve equitable access and uptake for patients to new innovations.

Within Europe, Mr Griffin has engaged through Company and Industry Association activities with EUnetHTA, with the aim of ensuring that what comes out of HTA collaboration across Europe is fit for purpose, with the ultimate aim of improving healthcare for patients.

Mr Griffin is currently on the Board of Directors of ISPOR, (the International Society for Pharmacoeconomics and Outcomes Research), and continues in his position as a member of the NICE Technology Appraisals Committee


Franz_Pichler2Franz Pichler, PhD
Director, Global Public Policy, Eli Lilly and Company

Franz Pichler has been Director, Global Public Policy at Eli Lilly and Company since 2012. This role encompasses development of external policy positions; provision of strategic advice; and external engagement around policy-related issues. A key focus of the role relates to the European environment, in particular with regards to Health Technology Assessment (HTA) and market access. He represents Lilly on the EuropaBio HTA and Market Access Group and the EFPIA HTA Task Force Steering Committee. He participates in the EUnetHTA Stakeholder Advisory Groups related to relative effectiveness assessment and methodological guidelines development. He is co-chair of the Medicines Adaptive Pathways to Patients initiative and is a participant of the Innovative Medicines Initiative (IMI) project ‘Incorporating real-life clinical data into drug development’ (GetREAL). He was a founding member of the HTAi interest sub group on HTA-Regulatory Interactions which he currently chairs. Franz joined Lilly after serving as the manager of the HTA Programme at the Centre for Innovation in Regulatory Science (CIRS) – a non-profit, independent medicines policy and research think tank. Prior to joining CIRS, Franz worked for over 10 years in molecular biology with specialties in functional genomics, population genetics and bioinformatics. He obtained his BSC in biology and PhD in population genetics at the University of Auckland in 1997 and 2002 respectively.


John_Arne_Rottingen_squareDr. John-Arne Røttingen
Norwegian Knowledge Centre for the Health Services

John-Arne Røttingen is Director of the Division of Infectious Disease Control at the Norwegian Institute of Public Health; Professor of Health Policy at the Department of Health Management and Health Economics, Institute of Health and Society, Faculty of Medicine, University of Oslo; Visiting Professor at the Department of Global Health and Population, Harvard School of Public Health; and Institute Visiting Scholar at the Harvard Global Health Institute.

He is Associate Fellow at the Centre on Global Health Security, Chatham House; research associate of the European Observatory on Health Systems and Policies; Chair of the Board of the Alliance for Health Policy and Systems Research; member of the Scientific Oversight Group of the Institute for Health Metrics and Evaluation, University of Washington, Seattle; and member of the International Advisory Committee for the Global Burden of Disease study.

He has been Director General of the Norwegian Knowledge Centre for the Health Services; Oxford Scholar at Wadham College; and Fulbright Fellow at Harvard Kennedy School.

He received his MD and PhD from the University of Oslo, an MSc from Oxford University and an MPA from Harvard University.


EvaMaria_Ruiz_de_CastillaEva Maria Ruiz de Castilla, PhD
Executive Director, Esperantra (NPO, Peru)

Dr. Eva Maria Ruiz de Castilla is a co-founder and since 2006 Executive Director of ESPERANTRA, a not-for-profit cancer and chronic disease patient advocacy organization in Lima, Peru. Her work at Esperantra is to improve the quality of life of patients with chronic conditions, health promotion, and to advance the recognition of the rights of patients to achieve access to timely diagnosis, treatment, and follow-up care. She has been instrumental in a number of national initiatives focused on cancer, including the government’s Plan Esperanza launched in 2012 to provide basic cancer care coverage for the poorest and most vulnerable Peruvians.

In addition to her work with Esperantra, Dr Ruiz de Castilla consults part-time for various Peruvian ministries, including Health, Social Development, Housing, Women, and Water-Sanitation to help design and coordinate the country’s public-sector social assistance programs. From 2011 to 2012, Dr Ruiz de Castilla was Director General of the Peruvian Ministry of Health’s (MINSA) International Coordination office and before that served as MINSA’s Director General of Health Prevention and Promotion. She has in-depth experience working with donor country agencies and multilateral organizations such as the World Bank.

As a Board Member of the International Alliance of Patients’ Organizations (IAPO) since 2010, Dr Ruiz de Castilla has been a global leader in patient-based organizational capacity building and has led various workshops on patient empowerment and networking. Her experience and involvement with building the capacity of civil society organizations focused on cancer in Peru earned her the American Cancer Society’s “Excelencia Latina 2009” Award. In 2011, Dr Ruiz de Castilla was named a Global Cancer Ambassador by the American Cancer Society, and was invited by the World Health Organization to participate as a civil society representative during the UN High-Level Meeting on non-communicable diseases (NCDs).

Dr Ruiz de Castilla’s academic credentials include degrees in Industrial Engineering and a PhD in Economic Development at the EHESS in Paris, France, and in Political Science at the Sorbonne University Paris 1. In Europe, she consulted for the United Nations on food and agriculture issues for the southern common market (MERCOSUR). Dr Ruiz de Castilla has authored a number of publications and papers on social development, health, and citizen engagement, and has been invited to speak at more than 200 national and international congresses.

GHF2014 – PS25 – Raising Awareness and Promoting Healthy Lifestyles: the Proof is in the Pudding

Raising Awareness and Promoting Healthy Lifestyles:
the Proof is in the Pudding

Dr. Sunoor Verma
Executive Director, Geneva Health Forum, Switzerland
FitNation/SémioFormation: Signs of Bikes for Public Health
Mr. Rick Bell
Executive Director, American Institute of Architects New York Chapter, Center for Architecture, United States
Ms. Gwenaëlle de Kerret
Research Director and Semiotician, Harris Interactive,
PhD. Candidate in socio-semiotics, Adjunct teacher in La Sorbonne (Paris V) and Rouen International Business School (NEOMA), France
Intervention with Communication Techniques Reduce Tobacco Use in the Community: An Experience from Rural Bangladesh
Mr. Shahidul Hoque
Field Research Manager, Centre for Equity and Health Systems, ICDDR, Bangladesh
Take a Step for Diabetes
Mr. Lorenzo Piemonte
Communications Coordinator, External Relations, International Diabetes Federation, Belgium

Sunoor -130Dr. Sunoor Verma

Dr. Sunoor Verma is the Executive Director Geneva Health Forum.As a senior development expert, Sunoor Verma has worked in emergency, conflict and post-conflict situations. He has led the establishment of complex partnerships and coalitions by negotiating strategic agreements and their implementation plans. He has set up programs across sectors, including, Education, Health, Protection, Injuries, Sanitation, HIV/AIDS, Harm Reduction, Conflict Resolution, Refugees, Internally Displaced Persons, Environment, Culture, Gender, Minority issues etc. He has worked in various locations, including Western Europe, South East Europe, South Asia, South East Asia, North Africa and Australia. Among others, he consulted and worked with UNHCR, UNICEF, and the European Centre for Minority Issues, Cambridge University and the Australian Society of Plastic Surgeons. Sunoor Vema has been the principal consultant of the strategy consulting practice ‘ProCube’ and is the founder of

He is a seasoned speaker on the topics of strategy, partnerships and leadership. He is also sought after for his skills as an effective moderator on high-voltage panels. In a previous avatar, Sunoor Verma was a practicing cardiothoracic surgeon.

PS25_Rick Bell_squareMr. Rick Bell

I became an architect because of the inspirational oratory of professors including Vincent Scully and the physical example of buildings seen while attempting, at the age of 19, to hitchhike from Paris to Dakar. As an architect I've had three careers, first in the private sector, then at a public agency, and, most recently, in the not-for-profit domain. As a private architect, I mostly designed schools and libraries in a NYC-based firm that also did hotel projects worldwide. In the public sector, I served as chief architect and assistant commissioner of New York City's public works department, responsible for 700 projects annually. And for the last twelve years I've led the New York Chapter of the American Institute of Architects and created its storefront Center for Architecture.

Gwen profile photoMs. Gwenaëlle de Kerret

Gwenaëlle joined Harris Interactive France in 2007, where she is responsible for semiotic and ethno-semiotic research. She has been working in marketing and communication research for 8 years, on French and international topics. She specializes in projects aiming at understanding how corporations’ territory impact on public’s perceptions. These projects involve either services and cultural products, or consumer goods (packagings, products) and commercial spaces.

In parallel, she has been working for 3 years on a PhD dissertation dedicated to museums’ visual identity, in Paris and NYC. This research focuses on how museums express their identity through graphics and space (communication, architecture, signage, etc.).

PS25_Piemonte Profile Photo_squareMr. Lorenzo Piemonte

An Italian national with a background in international relations, I’ve been based in Brussels for the last fifteen years, following periods of work and study in South Africa, the USA and UK. I joined the International Diabetes Federation (IDF) in 2003 and have been involved in several activities and projects for the Federation since then, including advocacy, communications, event management and public relations. My current responsibilities include coordination of the World Diabetes Day awareness campaign and overseeing the online communications of IDF. I’ve been living with type 1 diabetes for over 20 years.

GHF2014 – PS23 – Inclusive Decision Making and Local Health Policy Development

Inclusive Decision Making and Local Health Policy Development
Ms. Monika Christofori-Khadka, Health Advisor, Swiss Red Cross, Switzerland
Equity and Local Government: Sao Paulo, Brazil
Dr. Vera Coelho, Coordinator, Citizenship, Health and Development Group, Brazilian Centre of Analysis and Planning, Brazil
Inclusive Decision-Making and Community Empowerment for Health and Well-being: The Health Promotion and System Strengthening Project in Tanzania
Dr. Kate Molesworth, Senior Public Health Specialist and Reproductive Health and Social Development Adviser, Swiss Centre for International Health, Swiss Tropical and Public Health Institute, Switzerland
Strengthening Health Systems and Democracy Through the Empowerment of Rural Indigenous People for Rights Claiming in Guatemala
Dr. Walter Flores, Executive Director, Center for the Study of Equity and Governance in Health Systems, Guatemala

Khadka Profile PhotoMs. Monika Christofori-Khadka

Trained physiotherapist, working in several institutions in Germany.

1993-1996   Physiotherapist tutor in Tansen, Nepal

1999             Masters in Community Health, Liverpool School of Tropical Medicine, UK

2000-2005   Health Delegate in Bangladesh re-establishing and managing a MNCH programme of the Bangladesh Red Crescent  Society

2006-2012   Programme Coordinator for Kyrgystan, Nepal and China/Tibet with Swiss Red Cross, Switzerland

2010-2012   Masters in Health Economics, Policy and Management, London School of Economics, UK

Since 2013   Health Adviser of the Swiss Red Cross

VeraCoelhofoto (2)Dr. Vera Coelho

I have a PhD in social sciences in the area of “State and Public Policies” and I work at CEBRAP, an independent and interdisciplinary research center located in São Paulo, Brazil. I work with both qualitative and quantitative research methods, evaluating policies and coordinating comparative research projects in the areas of health systems, citizen involvement and pension reform. During the last twenty years I had some nice opportunities to combine professional responsibilities and personal interests as, for example, in 2008 when I went to the State of Gujarat in India to research the social justice committees at the panchayat, the local governance institutions. During my stay, I attended yoga classes, it was a great experience.

walter flores at IDRC-Beijing receptionDr. Walter Flores

Dr. Flores, a national from Guatemala, is a social scientist with over 20 years of professional experience. He holds a PhD and a Masters of Community Health from the Liverpool School of Tropical Medicine, UK.  His professional work has been carried-out in more than 20 countries from Latin America, Africa, Asia and Europe. His areas of expertise are:  health policy analysis, health equity, right to health, democratic governance of  public policies and community participation in public policies. Currently, Dr. Flores is the director of  Center for the Study of Equity and Governance in Health Systems), a civil society organization in Guatemala specialized in research, capacity building and advocacy around issues affecting indigenous and other marginalized populations (

GHF2014 – PS19 – Improving Access to Essential Medicines

Improving Access to Essential Medicines
Dr. Gilles Forte
Department for Essential Medicines and Health Products, World Health Organization, Switzerland
Strengthening Health Systems to Achieve Access to Essential Medicines
Ms. Alessandra Ferrario
Research Officer, Department of Social Policy, London School of Economics and Political Science, United Kingdom
Dr. Nicholas Banatvala
Noncommunicable Diseases and Mental Health Dept., World Health Organization, Switzerland
Dr. Nils Billo
International Union Against TB and Lung Disease, Switzerland
Ms. Maria Kathia Cárdenas
CRONICAS Centre, Universidad Peruana Cayetano Heredia, Lima, Peru
Dr. Julie Sarah Torode
Deputy CEO and Advocacy & Programmes Director, Union for International Cancer Control (UICC), Switzerland
Mr. Mario Ottiglio
Director, Public Affaires and Global Health Policy, International Federation of Pharmaceutical Manufacturers & Associations IFPMA, Switzerland
Ms. Margaret Ewen
Coordinator, Global Health Projects (Pricing), Health Action International (HAI), The Netherlands
This session at the Geneva Health Forum 2014 will aim to discuss the experience from different countries looking at barriers and facilitators to achieving the 80% target in different contexts and use this experience to see if lessons can be learnt on a global level and inform the implementation of concrete actions by different actors to reach this target. Following the presentation of country experiences different global actors will respond to the challenges presented as detail how they could see the problems being solved at what roles different stakeholders can play.

PS19_Gilles_ForteDr. Gilles Forte

Dr. Gilles Forte is the Coordinator of the “Essential Medicines and Health Products Policy, Access and Use team” at WHO headquarters. He is also Secretariat of expert committees on selection and use of medicines and on drug dependence.

Dr. Forte leads the development of guidance and tools for improving and monitoring WHO Member States policy, governance, access and use of medicines and health products, including for NCDs. Prior to this, he coordinated WHO medicines policy work in the WHO African Region.

Dr. Forte oversaw WHO collaboration with Countries of Central and Eastern Europe while based in the EURO Office in Copenhagen. He was also Medicines Policy and Supply officer for the WHO emergency operations in the former Yugoslavia. He is one of the authors of the WHO Guidelines for Drug Donations and has developed a series of emergency medical kits including for NCDs. Dr Forte has extensive experience of the NGO sector, having worked with a number of aid agencies involved in development and humanitarian programmes in Africa and Eastern Europe.

Trained in hospital pharmacy and public health, Dr. Forte holds a doctorate in pharmacy and a Master’s degree in pharmacology and nutrition. He has also held senior posts in the French public health system and at the national centre for scientific research.

Alessandra_Ferrario3Ms. Alessandra Ferrario

Alessandra Ferrario is a Research Officer in health policy at London School of Economics. Her research focuses on access to medicines and non-communicable diseases. One of her current research projects looks at improving budget impact and cost-effectiveness of pharmaceutical products through the introduction of managed entry agreements (MEAs). Over the past two years she has been working with the World Health Organization on issues around availability, affordability and quality of medicines in the Republic of Moldova.

Alessandra is also studying the burden and management of diabetes, both from a health and economic perspective, as part of a multi-country study in low- and middle-income countries. In previous projects she has investigated the determinants of price and utilisation differences for prescription medicines across OECD countries and issues related to good governance for medicines in low and middle income countries. She holds an MSc in Health Policy, Planning and Financing (LSE/LSHTM), MSc in Epidemiology (Swiss Tropical and Public Health Institute, University of Basel) and BSc in Molecular Biology (University of Basel).

Nick Banatvala_squareDr. Nicholas Banatvala

Dr Nick Banatvala is currently Senior Adviser to the Assistant Director General (Noncommunicable Diseases and Mental Health) at WHO in Geneva. Current responsibilities include leading development of a global coordination mechanism for the prevention and control of  NCDs, spearheading a newly set up UN NCD Taskforce and leading WHO’s global training programme to build capacity on NCDs for senior policy makers in middle and low-income countries.

Prior to this, Nick was Head of Global Affairs at the Department of Health in England where he led the development and implementation of the UK Government's first-ever global health strategy, its strategy for working with WHO and DH’s bilateral engagement with emerging economies. Before that, he headed up DFID’s work on global health initiatives and scaling up health services. This included leading on the health inputs for the 2005 G8 Gleneagles communiqué. He has represented the UK on a number of international initiatives, including the Global Fund to Fight AIDS, TB and Malaria and GAVI. Prior to this, Nick worked for DFID on health programmes in Pakistan, Afghanistan and the Middle East. Nick has experience of the NGO sector, having worked with the UK aid agency Merlin on development and humanitarian programmes.

Nick trained in paediatrics and infectious diseases and then did public health and epidemiologic research in the UK and at CDC, Atlanta. Nick has also held senior posts in UK public health. Nick has sat on government, non-government and academic boards, as well as national and international committees. He has undertaken consultancies for a number of agencies including the World Bank.

PS19_Nils_BilloDr. Nils Billo

Dr. Nils E. Billo, MD, MPH was Executive Director of the International Union Against Tuberculosis and Lung Disease (The Union) from 1992 to June 2013.

Under the leadership of Dr. Billo, The Union has grown into a leading international health organisation, with more than 10,000 members and subscribers in 152 countries, and some 300 staff and consultants working from Paris and regional and country offices in 13 countries. The Union's mandate has expanded to include not only tuberculosis and lung disease, but also some of today's most vital interrelated public health issues, such as child lung health, HIV/AIDS, the pandemic of diseases caused by tobacco use and non-communicable diseases (NCDs).

Dr. Billo completed his medical training at the University of Basel, Switzerland and holds a Master's of Public Health from the University of California, Berkeley. He was a member of the Stop TB Coordinating Board and past president of the Forum of International Respiratory Societies (FIRS), which organised the 2010 Year of the Lung campaign. Before joining The Union, he was head of the Epidemiology Section of the Federal Office of Public Health in Switzerland.

Dr. Billo is currently working as Senior Consultant for The Union.

PS06_Maria Kathia CardenasMs. Maria Kathia Cárdenas

Maria Kathia Cárdenas, BA, MSc(c), is a Peruvian investigator at CRONICAS Center of Excellence in Chronic Diseases at Universidad Peruana Cayetano Heredia (UPCH). Maria Kathia graduated from Economics and studied a Master in Epidemiological Research at UPCH through a Fellowship supported by The National Heart, Lung and Blood Institute (NHLBI) . Prior to her move to CRONICAS, she worked in areas devoted to Economic Evaluation of Projects and Public Policy in Social Development at two larger economic and development Think Tanks in Peru: Centro de Investigación de la Universidad del Pacífico and Instituto de Estudios Peruanos. Her area of interest is Health economics applied to chronic diseases.

She is the co-investigator in a research that received a seed grant award from NHLBI on lifestyles and cost of hypertension and she managed a health-system study looking into overcoming barriers to access care and treatment for chronic non-communicable diseases in Peru funded by the Alliance for Health Policy and Systems Research, World Health Organization. Currently, she is in charge of the economic evaluation of a large study launching a salt substitute to reduce blood pressure at the population level supported by the NHLBI under The Global Alliance for Chronic Diseases.

PS19_Julie_TorodeDr. Julie Torode

Based in Geneva, Julie Torode is Deputy CEO and Advocacy & Programmes.

Director of the Union for International Cancer Control (UICC).

In addition to managing some of the UICC flagship publications such as the TNM classification series and the International Journal of Cancer, Dr Torode has been instrumental in developing and instigating the UICC road map spanning global advocacy and 5 lead programmes. Influencing policy at the highest level includes leading UICCs campaign ahead of the High Level Meeting on NCDs in 2011, as well as UICCs work as founding federation of the NCD Alliance and the women’s task force on NCDs and health with partner organizations from the NCD, HIV-AIDs and reproductive health space. Recent work includes establishing programme leads on the Global Access to Pain Relief Initiative and Cervical Cancer Initiative as well as a review of the UICC fellowships and training offer. Dr Torode leads UICCs strategic relationships with key partners IARC (Global Initiative on Cancer registry Development), IAEA (PACT partnership) and WHO (joint work plan as NGO in official relations) as well as UICC members active in international cancer control.

Prior to joining UICC, she spent the last 10 years in Germany working in the pharmaceutical industry including phase I-IV clinical research - with a particular focus on breast and ovarian cancers, professional relations management and working with patient groups in oncology. She has a special interest in cancer prevention and palliative care. Dr Torode holds a PhD in Organic chemistry from the University of Liverpool.

PS19_Mario_Ottiglio_squareMr. Mario Ottiglio

Mario Ottiglio is Director at the IFPMA where he has been working since 2007 in positions of increasing responsibility. Mario leads on global health policy, coordinates IFPMA Members’ policy positions and conveys them to government and UN Specialized Agencies officials.

Mario also heads IFPMA’s public affairs and communications efforts, developing partnerships and promoting active dialogue with key stakeholders from governments, multilateral organizations, and civil society.

Prior to joining the IFPMA, Mario worked as a consultant for both the private sector and governments. Mario holds an MA in Political Science from the Naples Eastern University and is an Italian national.

PS19_Margaret_Ewen_squareMs. Margaret Ewen

Margaret is a pharmacist working on medicine price, availability and affordability issues at Health Action International (HAI) in Amsterdam.

In partnership with the World Health Organization, a methodology manual for measuring medicine prices, availability, affordability and price components was first published in 2003 (with a second edition published in 2008). To date, Marg has led or assisted more than 100 medicine price and availability surveys in all regions of the world, and provided pricing policy advice to numerous national governments.

She is currently looking at prices and affordability of NCD medicines in some Middle Eastern countries, and developing a methodology to compare prices of locally produced and imported medicines. Prior to joining HAI, Marg was a senior advisor at the Medicines Regulatory Authority (Medsafe) in her home country of New Zealand.

GHF2014 – PS18 – Improving Health Information Systems for Better Decision Making

Improving Health Information Systems for Better Decision Making
Mr. Hazim Timimi
Data Manager, Tuberculosis Monitoring and Evaluation, World Health OrganizationSwitzerland
Best Practices for Building an Integrated National Health Information System: Rwanda
Dr. Caricia Catalani
Senior Researcher, Innovative Support to Emergency, Disease, & Disaster (InSTEDD) & University of California, Berkeley, School of Public Health, United States
Prof. Don De Savigny
Head, Health Systems Interventions Research Unit, Department of Public Health and Epidemiology, Swiss Tropical and Public Health Institute, Switzerland

PS18_Catalani_squareDr. Caricia Catalani

I am a researcher, focusing on digital innovations for health.  I started working in the health field at age 16, as a physician’s assistant in our family-run urgent care clinic in the rainy Pacific Northwest of the United States. Since then, I’ve worked in an emergency room in a tough neighborhood in New York City, a sex workers’ union in the Dominican Republic, devastated neighborhoods in New Orleans after hurricane Katrina, US government health departments across the coasts, a cigar factory in Cuba, one of the world’s biggest private health insurance companies, a women’s health advocacy powerhouse in Washington, DC, a milky-eyed shamanic healer’s hut on the border of Cameroon, a teen health and empowerment center in San Francisco low-income housing, and clinics with mud floors and tin roofs throughout the African continent.  These days, I spend most of my time as a research consultant to eHealth, mHealth, and digital innovation projects at ministries of health, hospitals, and non-governmental organizations around the world (especially in Rwanda, Cambodia, Kenya, India, Canada, and the USA). I am faculty at the University of California, Berkeley, where I teach courses on digital innovations for health.  Awesome comedy improv and freestyle rap give me a lot of joy.  I spend countless hours learning from my four-month old and three-year old daughters, as we grow up together in the San Francisco Bay Area.

Don de Savigny_squareProf. Don de Savigny

Professor de Savigny is an epidemiologist and public health specialist and currently Head of the Health Systems Research Unit in the Department of Epidemiology and Public Health at the Swiss Tropical and Public Health Institute, University of Basel.  He has extensive experience in conducting and facilitating health research in developing countries and has lived and worked for many years in Africa.  He chairs or is a member of a number of WHO, RBM, Global Fund, and TDR advisory committees and networks such as COHRED, the Health Metrics Network and the INDEPTH Network.  His current research focuses on interventions to strengthen health systems in developing countries, and on the health system effects of Global Health Initiatives for scaling up access.

Immunization status of young people attending a youth clinic in Geneva, Switzerland

Author(s) Anne Meynard1, Emilien Jeannot2, Lydia Markham3, Claire-Anne Lazarevic 4, Bernard Cerutti 5, Francoise Narring6
Affiliation(s) 1Department of Pediatrics, Geneca University Hospitals, Geneva, Switzerland, 2Institute of social and preventive medicine, Faculty of Medicine, University of Geneva, Institute of social and preventive medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland, 3Private general practice, Private general practice and school health service, Nyon, Switzerland, 4School Health Service , Department of Public instruction Geneva, Geneva, Switzerland, 5Faculty of medicine University of Geneva, Faculty of medicine University of Geneva, Geneva, Switzerland, 6Department of Pediatrics, University hospitals Geneva, Geneva, Switzerland.
Country - ies of focus Switzerland
Relevant to the conference tracks Advocacy and Communication
Summary This study aims to describe immunization status at first visit in a collective of young people coming to an academic youth clinic. Results confirm our hypothesis that many young immigrants have had adequate childhood vaccination especially for tetanus but  are missing Hepatitis B and HPV. Collaboration between nurses in the youth clinic and school health services allows, not only detection of under-vaccinated youth, but quick and effective vaccination .
Background Adolescents are under-vaccinated and have limited access to effective care or preventive services in many regions of the world. Data on immunization status of adolescents or young adults in Switzerland are scarce and little is known about barriers to adequate coverage. Swiss vaccination coverage data shows that children of foreign origin are usually better immunized, but that this difference is lost in adolescence, where the most important factor of adequate vaccination is the presence of a school health vaccination program.
Objectives The objective is to describe the immunization status at first visit and differences in immunization status according to duration of stay in Switzerland and nationality of young people coming to a mulitdisicplinary youth clinic in Geneva
Methodology Immunization status at first visit (medical file, immunization booklets or school health database) was collected retrospectively between January 2010 and June 2011 in all patients coming for a first visit at Geneva University hospital’s multidisicplinary youth clinic. The main outcomes were Tetanus antibody titers one month after a booster of tetanus containing regimen and immunization status at first visit and the comparing of rates between young people of Swiss or foreign origin and for foreigners according to duration of stay in Switzerland.
Results 89% of patients tested for tetanus antibodies had values above 1000 U/l indicating adequate childhood immunization with 29% above 10’000 U/l putting them at risk of hyperimmunization if given usual adult catch up regimens (3 dosis). On the contrary Hepatitis B serology was often negative among the same population in our sample. Finding written information about immunization is significantely higher in youth born in Switzerland regardless of sex and nationality for all vaccines studied (tetanus, measles, hepatitis B and HPV) but is inferior to Swiss vaccination coverage data. Collection of information was highly facilitated by collaboration between academic youth clinic and school health services.
Conclusion In the absence of data, many young people immunized against tetanus or measles might in fact already be well immunized for childhood vaccinations. Effective collaboration between school-health services, primary health care facilities and youth clinics is highly effective in improving adolescent vaccine coverage especially with the help of public heath policies. School health services are usually very well informed about vaccination strategies in countries of immigration and the WHO database can also help to adapt recommendations to migratory flows.  However, they might miss young people at higher risk of being under or over immunized for example those with no booklet, absent from school on the day of immunization campaign, or with no permanent address. In Switzerland, parental consent is required for Hepatitis B or HPV immunization for young people under 16 years of age.Individually adapted catch-up immunization plans for adolescents and young adults regardless of origin or gender can avoid unnecessary and unsafe vaccination, and bring attention to barriers to adolescent vaccination as well as other adolescent health issues. Individual counseling allows targeted screening for silent infectious diseases (STI’s, Hepatitis, Chagas disease or common parasitic infections) but should mainly focus on assessment of protective and risk factors for healthy development of young people.